Celgene, stricken by setbacks, bids a quiet goodbye to dealmaking czar Golumbeski

Celgene, stricken by setbacks, bids a quiet goodbye to dealmaking czar Golumbeski

Source: 
Fierce Pharma
snippet: 

Celgene has suffered a series of damaging stumbles over the last year, culminating last month with the exit of chief operating officer Scott Smith. In a quieter apparent departure, business development head George Golumbeski left the company in April as well.